Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2‐Positive Breast Cancer.
Saved in:
| Title: | Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2‐Positive Breast Cancer. |
|---|---|
| Authors: | Otoya, Iris1 (AUTHOR) iris.otoyaf@gmail.com, Valdiviezo, Natalia1 (AUTHOR), Morante, Zaida1 (AUTHOR), Calle, Cindy1 (AUTHOR), Ferreyra, Yomali2 (AUTHOR), Huarcaya-Chombo, Norma3 (AUTHOR), Polo-Mendoza, Gabriela2 (AUTHOR), Castañeda, Carlos1 (AUTHOR), Vidaurre, Tatiana1 (AUTHOR), Neciosup, Silvia P.1 (AUTHOR), Calderón, Mónica J.1,4 (AUTHOR), Gomez, Henry L.1,4,5 (AUTHOR), Sahgal, Pranshu (AUTHOR) pranshu_sahgal@dfci.harvard.edu |
| Source: | International Journal of Breast Cancer. 6/22/2024, Vol. 2024, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
